E-LIB Suche - Ergebnisse für: Gilmartin, G.

1

WS11.5 Evaluation of combinations of the CFTR potentiator d..:

Downey, D. G ; Fajac, I. ; Flume, P....
Journal of Cystic Fibrosis. 19 (2020) - p. S19 , 2020

Link: https://doi.org/10.1016/..

2

WS11.2 Initial evaluation of the ex vivo response to the CF..:

van Mourik, P. ; Bierlaagh, M. ; Vonk, A....
Journal of Cystic Fibrosis. 19 (2020) - p. S18 , 2020

Link: https://doi.org/10.1016/..

3

WS06-2 Initial results evaluating the add-on effect of the ..:

Jain, M. ; Pilewski, J. ; Flume, P....
Journal of Cystic Fibrosis. 18 (2019) - p. S10-S11 , 2019

Link: https://doi.org/10.1016/..

4

WS06-1 Initial results evaluating combinations of the novel..:

Downey, D. ; Flume, P. ; Jain, M....
Journal of Cystic Fibrosis. 18 (2019) - p. S10 , 2019

Link: https://doi.org/10.1016/..

5

WS01.2 Phase 2 initial results evaluating PTI-428, a novel ..:

Flume, P. ; Sawicki, G. ; Pressler, T....
Journal of Cystic Fibrosis. 17 (2018) - p. S1-S2 , 2018

Link: https://doi.org/10.1016/..

6

WS13.2 Phase 1 initial results evaluating novel CFTR amplif..:

Gilmartin, G. ; Flume, P.A. ; Layish, D....
Journal of Cystic Fibrosis. 16 (2017) - p. S23 , 2017

Link: https://doi.org/10.1016/..

7

WS1.1 The effect of ivacaftor, a CFTR potentiator, in patie..:

De Boeck, K. ; Munck, A. ; Walker, S....
Journal of Cystic Fibrosis. 13 (2014) - p. S1 , 2014

Link: https://doi.org/10.1016/..

8

582 POSTER An acquired point mutation in MEK2 causes resist..:

Kusnierz, A.M. ; Gilmartin, A.G. ; Bleam, M.R....
European Journal of Cancer Supplements. 6 (2008) 12 - p. 182 , 2008

Link: https://doi.org/10.1016/..

9

567 POSTER GSK1120212 is a novel Mek inhibitor demonstratin..:

Gilmartin, A.G. ; Kusnierz, A.M. ; Sutton, D....
European Journal of Cancer Supplements. 6 (2008) 12 - p. 178 , 2008

Link: https://doi.org/10.1016/..

10

TNF-α modulates angiopoietin-1 expression in rheumatoid syn..:

Scott, B.B. ; Zaratin, P.F. ; Gilmartin, A.G....
Biochemical and Biophysical Research Communications. 328 (2005) 2 - p. 409-414 , 2005

Link: https://doi.org/10.1016/..

11

Regulated 3? processing of histone mRNA requires both the U..:

Birnstiel, M. L. ; Gick, O. ; Gilmartin, G...
Molecular Biology Reports. 12 (1987) 3 - p. 193-193 , 1987

Link: https://doi.org/10.1007/..

12

CPSF recognition of an HIV-1 mRNA 3'-processing enhancer: m..:

Gilmartin, G M ; Fleming, E S ; Oetjen, J.
Genes & Development. 9 (1995) 1 - p. 72-83 , 1995

Link: https://doi.org/10.1101/..

13

An ordered pathway of assembly of components required for p..:

Gilmartin, G M ; Nevins, J R
Genes & Development. 3 (1989) 12b - p. 2180-2190 , 1989

Link: https://doi.org/10.1101/..

14

Multiple factors are required for specific RNA cleavage at ..:

Gilmartin, G M ; McDevitt, M A ; Nevins, J R
Genes & Development. 2 (1988) 5 - p. 578-587 , 1988

Link: https://doi.org/10.1101/..

15

Multiple factors are required for poly(A) addition to a mRN..:

McDevitt, M A ; Gilmartin, G M ; Reeves, W H.
Genes & Development. 2 (1988) 5 - p. 588-597 , 1988

Link: https://doi.org/10.1101/..